AI
Monday, July 26, 2010 6:18:52 PM
Only disadvantage that I see is that it might make the FDAmore eager to approve Teva's offering.
Logical and reasonable - as always.
An inference from that reasonable and logical statement is that Sandoz thinks TEVA's L is not approvable. If they thought it a close call they would not want to push the FDA.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
